Until an effective vaccine becomes widely available for COVID-19, a frequent home test of the coronavirus on a weekly basis might become a new norm. Therefore, developing rapid, accurate, stable, and cost-effective tests is critical for combatting the spread of COVID-19 over the long term. Aptamers are single-stranded DNA oligonucleotides that can be selected from […]

With increasing amounts of information available online on the web, it’s crucial for search engines to filter out the content they think is useful and rank that content in decreasing order of relevance to the user’s query so that the user can just focus on the top results. Traditional techniques in search ranking focused on […]

Dose has developed a new probiotic that targets several aspects of oral and respiratory health. This project aims to understand the exact mechanism of our probiotic’s inhibitory properties against the pathogens associated with the above diseases. Dose is a new start-up in the probiotic/microbiome health sector, and this project will allow for improved technology and […]

The wide-spread adoption of digital pathology has opened new horizons for histopathology. Artificial intelligence (AI) algorithms are able to operate on digitized slides to assist pathologists with different tasks. Whereas AI involving classification and segmentation methods have obvious benefits for image analysis, image search represents a fundamental shift in computational pathology. Image-based search for digitized […]

Leveraging the entirety of point of sale and loyalty data collected across a category, as well as additional socio-economic and other supporting data sources, apply statistical modelling to identify the own-price elasticity of demand and cross-price elasticity of demand at regular and promoted price points across Unilever’s portfolio within that category. Subsequently measuring the promotional […]

The project aims to optimize healthcare provider and patient safety and monitor PPE use, to optimize resource utilization during the COVID-19 pandemic. Assessment of surgical data from an operating room is a complex process that may require significant resources such as expert input and advanced technology. Automation brings a considerable opportunity to greatly reducing these […]

Finding the right real estate property that grows in value over the next few years is of paramount importance. For doing so, one of the most important factors is to estimate the current value of the property as well as its future value. The goal of this project is to build a data and domain-driven […]

In Canada, as of April 21, only 569,878 people (~1.5% of the population) have been tested, with more than 38,413 positive COVID-19 cases identified; yet most people, including the asymptomatic COVID-19 cases, are not eligible for testing. Given that as many as 45% of all COVID-19 cases lack the known symptoms, or so-called asymptomatic cases, […]

As of 15 May 2020, more than 4.4 million COVID-19 cases have been reported across 188 countries and territories, resulting in more than 300,000 deaths. According to the World Health Organization reports, one of the main routes for transmission of COVID-19 and other infectious diseases is by contact with surfaces in public spaces that are […]

This project will undertake the development of a cost-effective, continuous monitoring, wireless temperature sensor. The sensor development undertaken with NURO will integrate the hardware with software algorithms designed to track and deliver a simple output for healthcare monitoring. The device is anticipated to be employed for tracking of COVID-19 in front line workers by monitoring […]

As of May 1st, 2020, over 3.2 million cases of COVID-19 have been confirmed, resulting in over 233,000 deaths globally. This project aims to provide an alternative vaccine for the prevention and treatment COVID-19 in high risk individuals, mainly the elderly and immunocompromised, who do not respond well to tranditional vaccination. Using a single viral […]

The goal of this study will be to characterize a SARS-CoV2 antigen and the formulated drug product that will contain SARS-CoV2 antigen and a squalene-based adjuvant under tight timeline to release the material for COVID-19 vaccine clinical trials.